Pimicotinib Significantly Improved Outcomes for Patients with Tenosynovial Giant Cell Tumor in a Glo
资讯
2024-11-12
Merck, a leading science and technology company, today announced that the Phase III MANEUVER trial of pimicotinib, an investigational medicine being developed by Abbisko Therapeutics Co., Ltd., met its primary endpoint, demonstrating significant improveme